Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg. After a $300 million round of Series D funding in 2021, CEO Perez said "We’re targeting a 2022 IPO. We've passed $100 million revenue with clear momentum to $200 million." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Hinge Health is a digital healthcare provider that specializes in treating musculoskeletal pain with therapy plans, wearable sensors, health coaching. The company seeks to make treatment more accessible while reducing surgery and opioid prescription rates. in 2021, Hinge Health acquired ENSO, a maker of non-invasive pain relief devices, and wrnch, a developer of human motion-tracking software. Per a company press release, Hinge Health has raised more than $1 billion in venture capital funding from investors including Coatue Management, Tiger Global Management, Alkeon Capital Management, and Whale Rock Capital Management. The company reports a post-money valuation of $6.2 billion.